Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations and Comprehensive Loss

v3.25.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Revenue $ 12,799 $ 17,925
Cost of revenue 5,954 8,414
Gross profit 6,845 9,511
Operating expenses:    
Sales and marketing 7,154 7,308
Research and development 3,031 3,874
General and Administrative Expense 9,986 8,789
Total operating expenses 20,171 19,971
Loss from operations (13,326) (10,460)
Other income (expense), net:    
Interest expense, net (309) (269)
Gain on revaluation of warrant liabilities 1 474
Loss on modification of warrant 0 (109)
Unrealized gain (loss) on foreign exchange 1,965 (965)
Other expense, net (26) (1)
Total other income (expense), net 1,631 (870)
Net loss (11,695) (11,330)
Foreign currency translation adjustments (1,649) 801
Comprehensive loss $ (13,344) $ (10,529)
Net loss per share applicable to common shareholders, basic and diluted (in dollars per share) $ (4.91) $ (8.43)
Weighted average number of shares outstanding, basic and diluted (in shares) 2,426 1,344